Compare · CNVY vs WGS
CNVY vs WGS
Side-by-side comparison of Convey Health Solutions Holdings Inc. (CNVY) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNVY and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- WGS is the larger of the two at $2.61B, about 4.8x CNVY ($540.9M).
- WGS has hit the wire 8 times in the past 4 weeks while CNVY has been quiet.
- Both have 8 recent analyst ratings on file.
- Company
- Convey Health Solutions Holdings Inc.
- GeneDx Holdings Corp.
- Price
- $10.54-0.19%
- $90.25+3.27%
- Market cap
- $540.9M
- $2.61B
- 1M return
- -
- +45.67%
- 1Y return
- -
- -28.43%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- 2020
- News (4w)
- 0
- 8
- Recent ratings
- 8
- 8
Convey Health Solutions Holdings Inc.
Convey Holding Parent, Inc., together with its subsidiaries, provides technology enabled solutions and advisory services to assist its clients with workflows across product developments, sales, member experience, clinical management, core operations, and business intelligence and analytics in the United States. It operates through two segments, Technology Enabled Solutions and Advisory Services. The Technology Enabled Solutions segment offers technology solutions through web-based customizable application that is used to identify, track, and administer contractual services, or benefits provided under a client's plan to its Medicare and Medicaid beneficiaries. It also provides analytics over healthcare data to capture and assess gaps in risk documentation, quality, clinical care, and compliance. The company's software solutions for health plans include enrollment and billing technology, supplemental benefits solution, agent and broker management, membership and financial reconciliation, compliance monitoring, and data analytic solutions. The Advisory Services segment offers advisory services, including sales and marketing strategies, provider network strategies, compliance, star ratings, quality, clinical, pharmacy, analytics, and risk adjustment. The company serves government sponsored, medicare, medicaid, and provided sponsored plans, as well as pharmacy benefits managers. The company was founded in 2001 and is headquartered in Fort Lauderdale, Florida. Convey Holding Parent, Inc. is a subsidiary of TPG Cannes Aggregation, L.P.
Latest CNVY
- SEC Form SC 13G/A filed by Convey Health Solutions Holdings Inc. (Amendment)
- SEC Form 15-12G filed by Convey Health Solutions Holdings Inc.
- SEC Form 4: Steele John E. returned $1,915,148 worth of shares to the company (182,395 units at $10.50), decreasing direct ownership by 97% to 5,775 units
- SEC Form 4 filed by Mansukani Sharad
- SEC Form 4: Whitmer William Carl returned $264,600 worth of shares to the company (25,200 units at $10.50), closing all direct ownership in the company
- SEC Form 4: Fairbanks Timothy returned $559,514 worth of shares to the company (53,287 units at $10.50), decreasing direct ownership by 96% to 2,131 units
- SEC Form 4 filed by Pichardo Susana
- SEC Form 4 filed by Campanelli Paul
- SEC Form 4: Stern Kyle returned $1,619,006 worth of shares to the company (154,191 units at $10.50), decreasing direct ownership by 97% to 4,636 units
- SEC Form 4: Farrell Stephen C returned $1,715,416 worth of shares to the company (163,373 units at $10.50), decreasing direct ownership by 97% to 4,734 units
Latest WGS
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
- SEC Form SCHEDULE 13G filed by GeneDx Holdings Corp.
- GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
- Amendment: SEC Form SCHEDULE 13G/A filed by GeneDx Holdings Corp.
- GeneDx to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports Second Quarter 2026 Financial Results
- SEC Form 25-NSE filed by GeneDx Holdings Corp.
- GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026